Chronic Low Grade Inflammation in Pathogenesis of PCOS
Open accessThe DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant clinical implications and can lead to health problems related to the accumulation of adipose tissue, such as obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. There is also evidence that PCOS patients are at higher risk of cardiovascular diseases, atherosclerosis, and high blood pressure. Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation. According to known data, inflammatory markers or their gene markers are higher in PCOS patients. Correlations have been found between increased levels of C-reactive protein (CRP), interleukin 18 (IL-18), tumor necrosis factor (TNF-α), interleukin 6 (IL-6), white blood cell count (WBC), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) in the PCOS women compared with age- and BMI-matched controls. Women with PCOS present also elevated levels of AGEs and increased RAGE (receptor for advanced glycation end products) expression. This chronic inflammatory state is aggravating by obesity and hyperinsulinemia. There are studies describing mutual impact of hyperinsulinemia and obesity, hyperandrogenism, and inflammatory state. Endothelial cell dysfunction may be also triggered by inflammatory cytokines. Many factors involved in oxidative stress, inflammation, and thrombosis were proposed as cardiovascular risk markers showing the endothelial cell damage in PCOS. Those markers include asymmetric dimethylarginine (ADMA), C-reactive protein (CRP), homocysteine, plasminogen activator inhibitor-I (PAI-I), PAI-I activity, vascular endothelial growth factor (VEGF) etc. It was also proposed that the uterine hyperinflammatory state in polycystic ovary syndrome may be responsible for significant pregnancy complications ranging from miscarriage to placental insufficiency. In this review, we discuss the most importance evidence concerning the role of the process of chronic inflammation in pathogenesis of PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“COCs also exacerbate the inflammatory state present in these patients, which is likely related to increased aldosterone–renin ratio and CRP [12,14].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“The release of inflammatory markers is associated with long-term metabolic complications and high cardiovascular risk [12].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Compared with control women, patients with PCOS presented higher circulating concentrations of markers such as homocysteine, asymmetric dimethylarginine, and increased superoxide dismutase activity and decreased glutathione levels and paraoxonase-1 activity [2].”
BackgroundMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186 · cited 1×
“Obesity is a metabolic condition characterized by chronic inflammation state with higher pro-inflammatory cytokines, chemokines, and oxidative stress (OS) markers levels [5,6].”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Metabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Cited by
Items 701–731 of 731
Ojo, P. O., Rotimi, D. E., Ezenabor, E. H., Akanji, M. A., & Adeyemı, O. S. (2026) · Discover Medicine · doi:10.1007/s44337-026-00686-6
Zhang, S., Xu, Y., Cao, T., Wang, K., Jia, L., & Li, J. (2026) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2026.2711737
Polycystic ovary syndrome phenotypes in Iranian infertile women: a cross-sectional study
Borujerdi, N. R., Khales, S. A., Esmaily, H., & Mahmoudinia, M. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00358-6
Said, S. S., Okafor, C. J., & Simai, B. O. (2026) · Apollo Medicine · doi:10.1177/09760016261476378
Qin, H., Huang, Y., Shen, Y., Chen, R., Zhong, W., Deng, H., Zhang, S., Xiao, Y., Huo, P., & Li, L. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107515
Abdulsalam, S. O., Akanbi, D. A., Aloba, T. E., Ogunlola, M. W., & Owopetu, D. I. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.20.753005
Sahu, G., & Goyal, A. K. (2026) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2026.102678
Altyar, A. E., Dessouky, D. Y., Salem, S. A. M., Salem, H. F., & Boshra, M. S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1822226
Gałczyńska, D., Przybyła, N., Wołkowska-Pokrywa, K., Wojtowicz, T., Kiecka, K., Pluta, D., & Franik, G. (2026) · Biomedicines · doi:10.3390/biomedicines14102215
Amiri, M., Kamrani, M. A., Qaderi, K., & Amoli, M. M. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02226-0
qizi, A. S. B. (2026) · Research Journal of Trauma and Disability Studies
Jasim, R. H. (2024) · CAHIERS MAGELLANES-NS
Insulin resistance: A key player in the onset of diverse disease pathologies
Aswal, P., Setya, S., Jangwan, N. S., Farswan, A. S., & Singh, M. F. (2026) · Vietnam Journal of Science and Technology/Science and Technology · doi:10.15625/2525-2518/19547
Shruti, & Bala, K. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02220-6
Li, X., Zeng, X., Ling, X., Zhang, J., & Zhao, C. L. (2026) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.70344
Prasad, A., Kishan, A., & Keezhadath, S. (2026) · Metabolites · doi:10.3390/metabo16100758
Kowalczyk-Guzikowska, S., Olanin, D., Winczewska, Z., Bartnicka, A., Karabin, K., & Drosdzol-Cop, A. B. (2026) · Ginekologia Polska · doi:10.5603/gpl.113813
Oguzhanoglu, M. K., & Oguzhanoglu, K. (2026) · Metabolites · doi:10.3390/metabo16100771
Cheng, X., Li, Y., Zhu, M., 蔡亞潔, Wei, N., Liu, Y., & Liu, Y. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.10.002
Φραγκούλη, Χ. Ν. (2026) · University of Thessaly Institutional Repository (University of Thessaly)
黄伟伟, Yu, C., Wang, Y., Sun, N., Wang, L., Ren, J., Xu, Y., Guo, X., Li, X., Mao, Y., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01625-6
Wang, X., Liu, C., Zhang, Z., Huang, Y., Liu, Z., Song, Y., Hu, R., Ma, W., Song, K., Zhang, M., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122542
Talebi, S. F., Shoorei, H., Bhandari, R. K., Farjah, G. H., Topraghaleh, T. R., & Abedpour, N. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110675
Szczuko, M., Skórka-Majewicz, M., Żwierełło, W., Pęcak, A., Rudak, L., Szczuko, U., & Pokorska‐Niewiada, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219626
Li, W., Liao, Y., Zhang, G., Zhang, F., Yan, H., Liu, J., Jiang, M., Zhao, Y., Xie, H., Ma, J., et al. (2026) · Reproduction · doi:10.1093/reprod/xaag137
Chusna, S. M., Farida, L. S., & Sutrisno, S. (2026) · ASIAN JOURNAL OF FERTILITY ENDOCRINOLOGY AND REPRODUCTION · doi:10.66060/ajfer.v1i4.26
Hasan, B., Bash, A., & Hamza, L. (2026) · Babcock University Medical Journal · doi:10.38029/babcockuniv.med.j..v9is1.1644
Hua, Z., Shen, L., & Chen, W.-N. (2026) · Journal of International Medical Research · doi:10.1177/03000605261485737
Ukam, C. I.-O., Markus, D., Onyinye, O. C., Egbung, J. E., Ajen, M. U., Uti, D. E., Okwueze, I. S., & Egbung, G. E. (2026) · Reproductive Toxicology · doi:10.1016/j.reprotox.2026.109399
Diagnosis and Multidisciplinary Management of Polyendocrine Metabolic Ovarian Syndrome
Valdez‐Sinon, A. N., Hosseinzadeh, P., & Moragianni, V. A. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.08.004 · Cited by 1
Metadata
- Authors
- Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B.
- Affiliations
- Medical University of Warsaw (PL)
- Warsaw University of Life Sciences (PL)
- Department of Gynaecological Endocrinology, Poznan University of Medical Sciences, 60-535 Poznan, Poland
- Corresponding author
- Rudnicka, Ewa
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-06
- Volume
- 22
- Issue
- 7
- Pages
- 3789
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8038770
- OpenAlex
- W3145310045
- Cited by
- 680
- References
- 99
- Citations by year
- 2026: 152 · 2025: 172 · 2024: 165 · 2023: 112 · 2022: 74 · 2021: 5
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, low-grade inflammation, inflammatory cytokines, C-reactive protein, advanced glycation end products, RAGE, hyperinsulinemia, obesity, endothelial dysfunction, oxidative stress, cardiovascular risk, pregnancy complications, hyperandrogenism, insulin resistance
- MeSH terms
- Aging, C-Reactive Protein, Chronic Disease, Diabetes Mellitus, Type 2, Female, Humans, Inflammation, Obesity, Polycystic Ovary Syndrome, Cytokines, Metabolic Syndrome, Endothelial Cells, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.